InvestLog
IOVA logo

IOVA

Iovance Biotherapeutics, Inc.NASDAQHealthcare
$3.43-0.58%ClosedMarket Cap: $1.14B

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-05UBS—Neutral—
2026-03-03Citizens—Market Outperform—
2026-02-25Barclays—Overweight—
2025-12-17Barclays—Overweight—
2025-11-06Chardan Capital—Buy—
2025-10-29HC Wainwright & Co.—Buy—
2025-08-19HC Wainwright & Co.—Buy—
2025-08-08Chardan Capital—Buy—
2025-08-08Wells Fargo—Overweight—
2025-05-16UBS—Neutral—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$-0.22$546.3M6
Sun Dec 31$0.01$735.8M6
Mon Dec 31$0.10$786.2M4
Tue Dec 31$0.22$872.1M2